Context: Sexual sensation seeking and sexual compulsivity are two characteristics associated with sexual risk taking and can be studied in different contexts, one of these being that of forensics. Among the different tools used to assess these characteristics, the Sexual Sensation Seeking Scale (SSSS) and the Sexual Compulsivity Scale (SCS) are particularly concise and specific.
Method: This study proposes a French translation of those scales, the fSSSS and the fSCS, validated among a sample of 536 participants from France. Assessments of factor structure, internal consistency and reliability showed good psychometric properties. Convergent and divergent validities were assessed using various forensic-related measures and demonstrated the relevance of both scales in this context.
Introduction: Social functioning is an individual's ability to interact effectively and appropriately with his or her social environment. In psychiatry, acting on social functioning is necessary to reduce the intensity of symptoms and promote patient life in the community. This study proposes a cross-cultural validation of the Social Functioning Questionnaire (SFQ) in Moroccan dialectal Arabic.
Methods: This work consists of creating a translated version according to a rigorous methodology, including direct and reverse translation, as well as evaluation by linguistic experts. A sample of 160 participants was then selected to evaluate the psychometric properties of the SFQ in a statistical study.
Results: The validation study showed high acceptability and reliability, with a Cronbach's alpha coefficient of 0.803. The results also showed good reproducibility, with perfect inter-observer stability between the test and the retests.
Conclusion: This version of the SFQ is reliable and valid for measuring social functioning in our Moroccan population.
Objectives: Psychiatric patients are frequently exposed to factors that increase their risk of developing chronic liver diseases. These factors include the presence of metabolic syndrome, high rates of current or past alcohol and illicit substance use, and the direct liver toxicity of certain psychiatric medications. Despite this, systematic screening for chronic liver diseases in this population is not routine. Transient elastography (FibroScan®), a non-invasive method to assess liver stiffness, could facilitate early detection of advanced hepatic fibrosis. This study aimed to assess the acceptability of non-invasive liver fibrosis evaluation using FibroScan® among psychiatric inpatients and to evaluate the prevalence of alcohol and illicit drug use, viral hepatitis, significant liver fibrosis, and linkage to somatic care.
Methods: This prospective, interventional cohort study was conducted in a tertiary psychiatric hospital from March 2023 to January 2024. Liver stiffness measurement (LSM) by transient elastography (FibroScan®) screening for the detection of significant liver fibrosis was proposed to all hospitalized patients after providing informed consent. Patients responded to a structured interview that included the AUDIT-C questionnaire to assess alcohol use disorders, along with items on illicit drug use and other liver disease risk factors like metabolic syndrome or viral hepatitis. Significant fibrosis was defined as liver stiffness measurement (LSM) ≥10kPa. Demographic, clinical, biological and virological data was collected from patients' medical files.
Results: A total of 180 patients were included in the study, with 122 (67.8%) consenting to FibroScan® screening. The cohort's mean age was 44.4±15.5 years, with 61% male. The seroprevalence of HCV antibodies was 2.5%, with a higher prevalence among men (6.5%). Chronic HBV infection prevalence was 0.81%. Metabolic syndrome was present in 28.7% of patients. Alcohol use disorders were identified in 45.9% of patients, with men showing higher AUDIT-C scores than women (P=0.04). Drug use was reported by 37.7% of patients, with recent use in 20%. Significant fibrosis was detected in 0.8% of patients and linkage to care was provided in this case.
Conclusions: Transient elastography is an acceptable method for screening hepatic fibrosis in psychiatric settings. It represents an excellent option to assess other associated comorbidities in this underserved population and improve linkage to somatic care.
Objectives: This project aimed to explore the impact of psychological distress (anxiety, depression and post-traumatic stress) and resilience on quality of life and psychological health at work (well-being or distress at work) of nursing home and healthcare staff members in the Moselle department in Northeastern France.
Methods: In the spring of 2021 230 professionals replied to an online questionnaire. The theoretical model was tested through path analyses.
Results: Results showed that higher resilience scores were associated with lower post-traumatic stress, anxiety, and depression scores. Anxiety and depression were negatively correlated with quality of life, while higher quality of life scores were linked to greater well-being at work. Resilience was found to have a significant impact on the psychological state of professionals, with differences observed between well-being and distress at work.
Discussion: In conclusion, our study revealed that resilience plays a significant role in influencing the psychological state of professionals, ultimately impacting their psychological health at work. Therefore, interventions aimed at addressing anxiety, depression, and traumatic symptoms could potentially enhance resilience and mitigate work-related psychological disorders among frontline healthcare professionals.
Insomnia disorder is a major health concern, particularly among patients with mood disorders. This study validates the translated version of the Insomnia Severity Index (ISI) in a French population with psychiatric disorders, particularly mood disorders. The ISI was completed by 260 patients with sleep complaints comorbid with psychiatric disorders, including 209 patients with mood disorders. The majority of participants were women (n=168), and the most diagnosed condition in the population was unipolar mood disorder (n=170). Internal and external validity analyses validated the scale's reliability and its validity in relation to sleep quality and a diagnosis of insomnia made by a sleep psychiatrist. These results support the use of the French translation of the ISI in a French population with psychiatric disorders.
Objectives: The present study investigates the prevalence of antinuclear autoantibodies among Moroccan patients with schizophrenia compared to healthy controls and examines the potential associations between the presence of antinuclear autoantibodies and selected sociodemographic and clinical characteristics of patients with schizophrenia.
Methods: A cross-sectional assessment was conducted between May 2020 and December 2022. The study involved a total of 157 patients who were diagnosed with schizophrenia and admitted to the Ar-Razi Psychiatric Hospital of Ibn Sina University Hospital Center of Rabat, Morocco. A total of 115 healthy controls (blood donors) were recruited from the transfusion center of Kenitra, Morocco. Antinuclear autoantibodies screening was performed by an indirect immunofluorescence assay (IFA) using HEp-2 cells/liver (Monkey), and 16 specificities of nuclear antigens (ENA) were tested using immunodot assay on an automated platform.
Results: The prevalence of antinuclear autoantibodies was significantly higher in patients as compared to healthy control (35 vs. 12.7% with P<0.05) suggesting strongly underlying autoimmune processes in the studied patients. Among the 55 samples tested positive for antinuclear autoantibodies in patients, a total of 29 samples had a positive immunodot result against the following antigens: Jo1, SSA, SSB, Ro 52, AMA-M2, PM-Scl, Sm and Sm/RNP. Logistic regression analysis identified tobacco consumption as the only significant predictor of positive antinuclear autoantibodies (B=2.179, P=0.018).
Conclusion: This preliminary study provides original data on the prevalence of antinuclear autoantibodies in Moroccan patients with schizophrenia and reveals a strong association between tobacco consumption and antinuclear autoantibodies positivity. The present findings replicate the previously reported association between autoimmune processes and schizophrenia in other geographical areas and warrant extension to other circulating autoantibodies towards a full profiling of autoimmunity in Moroccan patients with schizophrenia.

